HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Magnesium therapy in preeclampsia and HELLP syndrome--studies of pathophysiology].

Abstract
Aggregation und Serotonin-release were investigated depending on plasma magnesium levels. High magnesium levels inhibit the platelet function, which is stimulated in preeclamptic patients. Magnesium-infusions therefore might be of therapeutical use in SIH-patients by reducing the platelet function.
AuthorsA Hettenbach, M Possover, E Müller, B Stutz
JournalZentralblatt fur Gynakologie (Zentralbl Gynakol) Vol. 116 Issue 4 Pg. 213-6 ( 1994) ISSN: 0044-4197 [Print] Germany
Vernacular TitleMagnesiumtherapie bei Präeklampsie und beim HELLP-Syndrom--Untersuchungen zur Pathophysiologie.
PMID8023608 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Serotonin
  • Magnesium Sulfate
  • Magnesium
Topics
  • Dose-Response Relationship, Drug
  • Female
  • HELLP Syndrome (blood, drug therapy)
  • Humans
  • In Vitro Techniques
  • Infusions, Intravenous
  • Magnesium (blood)
  • Magnesium Sulfate (administration & dosage, pharmacokinetics)
  • Platelet Activation (drug effects, physiology)
  • Platelet Aggregation (drug effects, physiology)
  • Pre-Eclampsia (blood, drug therapy)
  • Pregnancy
  • Serotonin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: